15-Lipoxygenase-1 transcriptional silencing by DNA methyltransferase-1 independently of DNA methylation

FASEB Journal

Volumn 22, Issue 6, 2008, Pages 1981-1992

  Zuo, Xiangsheng ^a   Shen, Lanlan ^a   Issa, Jean Pierre ^a   Moy, Ofir ^a   Morris, Jeffrey S ^a   Lippman, Scott M ^a   Shureiqi, Imad ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Colon cancer; DNMT 1 hypomorph protein; Histone deacetylase inhibitor; Transcriptional regulation

Indexed keywords

15 LIPOXYGENASE 1; ARACHIDONATE 15 LIPOXYGENASE; DNA METHYLTRANSFERASE 1; HISTONE DEACETYLASE INHIBITOR; SMALL INTERFERING RNA; VORINOSTAT;

ADULT; AGED; ARTICLE; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN FUNCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ARACHIDONATE 15-LIPOXYGENASE; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DNA MODIFICATION METHYLASES; GENE SILENCING; HUMANS; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC;

EID: 44949214808     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.07-098301     Document Type: Article

References (50)

1. Jones, P. A., and Laird, P. W. (1999) Cancer-epigenetics comes of age. Nat. Genet. 21, 163-167
2. Baer, A. N., Costello, P. B., and Green, F. A. (1991) In vivo activation of an omega-6 oxygenase in human skin. Biochem. Biophys. Res. Commun. 180, 98-104
3. Brash, A. R., Boeglin, W. E., and Chang, M. S. (1997) Discovery of a second 15S-lipoxygenase in humans. Proc. Natl. Acad. Sci. U. S. A. 94, 6148-6152
4. Serhan, C. N., Jain, A., Marleau, S., Clish, C., Kantarci, A., Behbehani, B., Colgan, S. P., Stahl, G. L., Merched, A., Petasis, N. A., Chan, L., and Van Dyke, T. E. (2003) Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J. Immunol. 171, 6856-6865
5. Ariel, A., Li, P. L., Wang, W., Tang, W. X., Fredman, G., Hong, S., Gotlinger, K. H., and Serhan, C. N. (2005) The docosatriene protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clustering. J. Biol. Chem. 280, 43079-43086
6. Munger, K. A., Montero, A., Fukunaga, M., Uda, S., Yura, T., Imai, E., Kaneda, Y., Valdivielso, J. M., and Badr, K. F. (1999) Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis. Proc. Nat. Acad. Sci. 96, 13375-13380
7. Shureiqi, I., Wojno, K. J., Poore, J. A., Reddy, R. G., Moussalli, M. J., Spindler, S. A., Greenson, J. K., Normolle, D., Hasan, A. A., Lawrence, T. S., and Brenner, D. E. (1999) Decreased 13-Shydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers. Carcinogenesis 20, 1985-1995
8. Nixon, J. B., Kim, K. S., Lamb, P. W., Bottone, F. G., and Eling, T. E. (2004) 15-Lipoxygenase-1 has anti-tumorigenic effects in colorectal cancer Prostaglandins Leukot. Essent. Fatty Acids 70, 7-15
9. Heslin, M. J., Hawkins, A., Boedefeld, W., Arnoletti, J. P., Frolov, A., Soong, R., Urist, M. M., and Bland, K. I. (2005) Tumor-associated down-regulation of 15-lipoxygenase-1 is reversed by celecoxib in colorectal Cancer Ann. Surg. 241, 941-946; discussion 946-947
10. Shureiqi, I., Xu, X., Chen, D., Lotan, R., Morris, J. S., Fischer, S. M., and Lippman, S. M. (2001) Nonsteroidal anti-inflammatory drugs induce apoptosis in esophageal cancer cells by restoring 15-lipoxygenase-1 expression. Cancer Res. 61, 4879-4884
11. Jiang, W. G., Watkins, G., Douglas-Jones, A., and Mansel, R. E. (2006) Reduction of isoforms of 15-lipoxygenase (15-LOX)-1 and 15-LOX-2 in human breast cancer Prostaglandins Leukot. Essent. Fatty Acids 74, 235-245
12. Hennig, R., Kehl, T., Noor, S., Ding, X. Z., Rao, S. M., Bergmann, F., Furstenberger, G., Buchler, M. W., Friess, H., Krieg, P., and Adrian, T. E. (2007) 15-Lipoxygenase-1 production is lost in pancreatic cancer and overexpression of the gene inhibits tumor cell growth. Neoplasia 9, 917-926
13. Shureiqi, I., Chen, D., Lee, J. J., Yang, P., Newman, R. A., Brenner, D. E., Lotan, R., Fischer, S. M., and Lippman, S. M. (2000) 15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells. J. Natl. Cancer Inst. 92, 1136-1142
14. Shureiqi, I., Jiang, W., Zuo, X., Wu, Y., Stimmel, J. B., Leesnitzer, L. M., Morris, J. S., Fan, H. Z., Fischer, S. M., and Lippman, S. M. (2003) The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-delta to induce apoptosis in colorectal cancer cells. Proc. Natl. Acad. Sci. U. S. A. 100, 9968-9973
15. Wu, J., Xia, H. H., Tu, S. P., Fan, D. M., Lin, M. C., Kung, H. F., Lam, S. K., and Wong, B. C. (2003) 15-Lipoxygenase-1 mediates cyclooxygenase-2 inhibitor-induced apoptosis in gastric cancer Carcinogenesis 24, 243-247
16. Hsi, L. C., Xi, X., Lotan, R., Shureiqi, I., and Lippman, S. M. (2004) The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells. Cancer Res. 64, 8778-8781
17. Deguchi, A., Xing, S. W., Shureiqi, I., Yang, P., Newman, R. A., Lippman, S. M., Feinmark, S. J., Oehlen, B., and Weinstein, I. B. (2005) Activation of protein kinase G up-regulates expression of 15-lipoxygenase-1 in human colon cancer cells. Cancer Res. 65, 8442-8447
18. Shureiqi, I., Wu, Y., Chen, D., Yang, X. L., Guan, B., Morris, J. S., Yang, P., Newman, R. A., Broaddus, R., Hamilton, S. R., Lynch, P., Levin, B., Fischer, S. M., and Lippman, S. M. (2005) The critical role of 15-lipoxygenase-1 in colorectal epithelial cell terminal differentiation and tumorigenesis. Cancer Res. 65, 11486-11492
19. Zuo, X., Wu, Y., Morris, J. S., Stimmel, J. B., Leesnitzer, L. M., Fischer, S. M., Lippman, S. M., and Shureiqi, I. (2006) Oxidative metabolism of linoleic acid modulates PPAR-beta/delta suppression of PPAR-gamma activity. Oncogene 25, 1225-1241
20. Kelavkar, U., Wang, S., Montero, A., Murtagh, J., Shah, K., and Badr, K. (1998) Human 15-lipoxygenase gene promoter: analysis and identification of DNA binding sites for IL-13-induced regulatory factors in monocytes. Mol. Biol. Rep. 25, 173-182
21. Liu, C., Xu, D., Sjoberg, J., Forsell, P., Bjorkholm, M., and Claesson, H. E. (2004) Transcriptional regulation of 15-lipoxygenase expression by promoter methylation. Exp. Cell. Res. 297, 61-67
22. Kelavkar, U. P., Harya, N. S., Hutzley, J., Bacich, D. J., Monzon, F. A., Chandran, U., Dhir, R., and O'Keefe D, S. (2007) DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation. Prostaglandins Other Lipid. Mediat. 82, 185-197
23. Hsi, L. C., Xi, X., Wu, Y., and Lippman, S. M. (2005) The methyltransferase inhibitor 5-aza-2-deoxycytidine induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells. Mol. Cancer Ther. 4, 1740-1746
24. Kamitani, H., Taniura, S., Ikawa, H., Watanabe, T., Kelavkar, U. P., and Eling, T. E. (2001) Expression of 15-lipoxygenase-1 is regulated by histone acetylation in human colorectal carcinoma. Carcinogenesis 22, 187-191
25. Martinez, M. E., McPherson, R. S., Levin, B., and Glober, G. A. (1997) A case-control study of dietary intake and other lifestyle risk factors for hyperplastic polyps. Gastroenterology 113, 423-429
26. Martinez, M. E., McPherson, R. S., Levin, B., and Annegers, J. F. (1995) Aspirin and other nonsteroidal anti-inflammatory drugs and risk of colorectal adenomatous polyps among endoscoped individuals. Cancer Epidemiol. Biomarkers Prev. 4, 703-707
27. Shu, J., Jelinek, J., Chang, H., Shen, L., Qin, T., Chung, W., Oki, Y., and Issa, J. P. (2006) Silencing of bidirectional promoters by DNA methylation in tumorigenesis. Cancer Res. 66, 5077-5084
28. Pfaffl, M. W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45
29. Litt, M. D., Simpson, M., Recillas-Targa, F., Prioleau, M. N., and Felsenfeld, G. (2001) Transitions in histone acetylation reveal boundaries of three separately regulated neighboring loci. EMBO J. 20, 2224-2235
30. Wozniak, R. J., Klimecki, W. T., Lau, S. S., Feinstein, Y., and Futscher, B. W. (2007) 5-Aza-2′-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation. Oncogene 26, 77-90
31. Rhee, I., Bachman, K. E., Park, B. H., Jair, K.-W., Yen, R.-W. C., Schuebel, K. E., Cui, H., Feinberg, A. P., Lengauer, C., Kinzler, K. W., Baylin, S. B., and Vogelstein, B. (2002) DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 416, 552-556
32. Egger, G., Jeong, S., Escobar, S. G., Cortez, C. C., Li, T. W., Saito, Y., Yoo, C. B., Jones, P. A., and Liang, G. (2006) Identification of DNMT1 (DNA methyltransferase 1) hypomorphs in somatic knockouts suggests an essential role for DNMT1 in cell survival. Proc. Natl. Acad. Sci. U. S. A. 103, 14080-14085
33. Zhou, Q., Atadja, P., and Davidson, N. E. (2007) Histone deacetylase inhibitor LBH589 reactivates silenced estrogen receptor alpha (ER) gene expression without loss of DNA hypermethylation. Cancer Biol. Ther. 6, 64-69
34. Li, E., Bestor, T. H., and Jaenisch, R. (1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69, 915-926
35. Gaudet, F., Hodgson, J. G., Eden, A., Jackson-Grusby, L., Dausman, J., Gray, J. W., Leonhardt, H., and Jaenisch, R. (2003) Induction of tumors in mice by genomic hypomethylation. Science 300, 489-492
36. Robertson, K. D., Ait-Si-Ali, S., Yokochi, T., Wade, P. A., Jones, P. L., and Wolffe, A. P. (2000) DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2Fresponsive promoters. Nat. Genet. 25, 338-342
37. Rountree, M. R., Bachman, K. E., and Baylin, S. B. (2000) DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nat. Genet. 25, 269-277
38. Fuks, F., Burgers, W. A., Brehm, A., Hughes-Davies, L., and Kouzarides, T. (2000) DNA methyltransferase DNMT1 associates with histone deacetylase activity. Nat. Genet. 24, 88-91
39. Fuks, F., Hurd, P. J., Deplus, R., and Kouzarides, T. (2003) The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase. Nucleic Acids Res. 31, 2305-2312
40. Vire, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J. M., Bollen, M., Esteller, M., Di Croce, L., de Launoit, Y., and Fuks, F. (2006) The polycomb group protein EZH2 directly controls DNA methylation. Nature 439, 871-874
41. Makar, K. W., Perez-Melgosa, M., Shnyreva, M., Weaver, W. M., Fitzpatrick, D. R., and Wilson, C. B. (2003) Active recruitment of DNA methyltransferases regulates interleukin 4 in thymocytes and T cells. Nat. Immunol. 4, 1183-1190
42. Damelin, M., and Bestor, T. H. (2007) Biological functions of DNA methyltransferase 1 require its methyltransferase activity. Mol. Cell. Biol. 27, 3891-3899
43. Balkwill, F., Charles, K. A., and Mantovani, A. (2005) Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7, 211-217
44. Ekbom, A., Helmick, C., Zack, M., and Adami, H. O. (1990) Ulcerative colitis and colorectal cancer: a population-based study. N. Engl. J. Med. 323, 1228-1233
45. Ariel, A., and Serhan, C. N. (2007) Resolvins and protectins in the termination program of acute inflammation. Trends Immunol. 28, 176-183
46. Hodge, D. R., Xiao, W., Clausen, P. A., Heidecker, G., Szyf, M., and Farrar, W. L. (2001) Interleukin-6 regulation of the human DNA methyltransferase (HDNMT) gene in human erythroleukemia cells. J. Biol. Chem. 276, 39508-39511
47. Hodge, D. R., Peng, B., Cherry, J. C., Hurt, E. M., Fox, S. D., Kelley, J. A., Munroe, D. J., and Farrar, W. L. (2005) Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation. Cancer Res. 65, 4673-4682
48. Shureiqi, I., and Lippman, S. M. (2001) Lipoxygenase modulation to reverse carcinogenesis. Cancer Res. 61, 6307-6312
49. Kuhn, H., and O'Donnell, V. B. (2006) Inflammation and immune regulation by 12/15-lipoxygenases. Prog. Lipid Res. 45, 334-356
50. Massaro, M., Habib, A., Lubrano, L., Turco, S. D., Lazzerini, G., Bourcier, T., Weksler, B. B., and De Caterina, R. (2006) The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKCε inhibition. Proc. Natl. Acad. Sci. U. S. A. 103, 15184-15189